• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconValeant

Valeant

Page 6 of 12
FinanceInvestors in Female Viagra Are Slamming Valeant
By Lucinda ShenMarch 25, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
FinanceBill Ackman Asked for Information in Drug Pricing Probe
By ReutersMarch 24, 2016
Trading At The NYSE As Valeant Shares Halted Ahead of News Announcement
FinanceThe Head of a Buffett-Linked Fund Just Resigned Over Its Huge Valeant Stake
By Sy MukherjeeMarch 24, 2016
Trading At The NYSE As Valeant Shares Halted Ahead of News Announcement
FinanceThe Really Big Problem with Valeant’s Billions of Debt
By Lauren Silva LaughlinMarch 22, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
FinanceHere’s Why Valeant May Have Accused Its Former CFO of “Improper Conduct”
By ReutersMarch 21, 2016
Drug Hearing
FinanceValeant Infighting Is Getting Nasty
By Jen WiecznerMarch 21, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
HealthValeant Is Looking For a New CEO
By Phil WahbaMarch 21, 2016
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., speaks during their annual general meeting in Laval, Quebec
FinanceWhat Caused Valeant’s Epic 90% Plunge
By Stephen Gandel and ReutersMarch 20, 2016
Key Speakers At The Bloomberg Markets Most Influential Summit
FinanceThis Valeant Investor Is In Even Bigger Trouble than Bill Ackman
By Jen WiecznerMarch 18, 2016
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
FinanceValeant CEO Promises Company Won’t Go Bankrupt in Staff Memo
By Jen WiecznerMarch 18, 2016
Key Speakers At The Bloomberg Markets Most Influential Summit
FinanceAckman’s Hedge Fund Faces S&P Downgrade
By ReutersMarch 17, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
FinanceHere’s Why Valeant Shares Plummeted Again
By Laura LorenzettiMarch 17, 2016
House Oversight Hearing On Prescription Drug Price Increases
HealthMartin Shkreli’s Former Colleague: We Advised Him Against That Infamous Price Hike
By Sy MukherjeeMarch 17, 2016
Hedge fund manager Bill Ackman
FinanceAckman Sells Big Mondelez Stake Amid Major Losses
By ReutersMarch 16, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
LeadershipValeant to Walgreens: Hey, It’s Not Your Fault After All
By Jennifer ReingoldMarch 16, 2016
1...
  • 4
  • 5
  • 6
  • 7
  • 8
...12
Most Popular
Innovation
An MIT roboticist who cofounded bankrupt robot vacuum maker iRobot says Elon Musk’s vision of humanoid robot assistants is ‘pure fantasy thinking’An image of a popular article
By Marco Quiroz-GutierrezFebruary 25, 2026
Commentary
'The Pitt': a masterclass display of DEI in action An image of a popular article
By Robert RabenFebruary 26, 2026
Success
Japanese companies are paying older workers to sit by a window and do nothing—while Western CEOs demand super-AI productivity just to keep your jobAn image of a popular article
By Orianna Rosa RoyleFebruary 27, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
Fortune Secondary Logo
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.